Education, Employment, and Financial Outcomes in Adolescent and Young Adult Cancer Survivors-A Systematic Review

Curr Oncol. 2023 Sep 25;30(10):8720-8762. doi: 10.3390/curroncol30100631.

Abstract

Adolescents and young adults (AYAs) with cancer face unique challenges. We aimed to describe (i) education, employment, and financial outcomes and (ii) determinants for adverse outcomes in AYA cancer survivors. We performed a systematic literature search. We included original research articles on AYA (15-39 years of age) cancer survivors (≥2 years after diagnosis) and our outcomes of interest. We narratively synthesized the results of the included articles. We included 35 articles (24 quantitative and 11 qualitative studies). Patients in education had to interrupt their education during cancer treatment, and re-entry after treatment was challenging. After treatment, most survivors were employed but started their employment at an older age than the general population. Overall, no disadvantages in income were found. Survivors reported more absent workdays than comparisons. We identified chemotherapy, radiotherapy, late effects or health problems, female sex, migration background, and lower education associated with adverse outcomes. Although most AYA cancer survivors were able to re-enter education and employment, they reported difficulties with re-entry and delays in their employment pathway. To facilitate successful re-entry, age-tailored support services should be developed and implemented.

Keywords: adolescent and young adult; cancer; education; employment; financial outcomes; psychosocial health; survivors.

Publication types

  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Cancer Survivors*
  • Employment
  • Female
  • Humans
  • Neoplasms* / therapy
  • Quality of Life
  • Survivors
  • Young Adult

Grants and funding

This work was supported by Palatin-Stiftung Switzerland (Nr. 0028/2020 to KR), Krebsliga Zentralschweiz Switzerland (to KR), Avenira Stiftung Switzerland (to KR), and the Swiss National Science Foundation (SNSF, Nr. 10001C_182129/1 to GM).